Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus

Journal of the American College of Cardiology

Volumn 30, Issue 6, 1997, Pages 1472-1477

  Yokoyama, Ikuo ^a   Momomura, Shin Ichi ^a   Ohtake, Tohru ^a   Yonekura, Katsunori ^a   Nishikawa, Junichi ^a   Sasaki, Yasuhito ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; CHOLESTEROL; DIPYRIDAMOLE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; NITROGEN 13;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; HEART MUSCLE BLOOD FLOW; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

BLOOD GLUCOSE; CORONARY CIRCULATION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; SEX FACTORS;

EID: 0030725383     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00327-6     Document Type: Article

References (38)

1. Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 1974;34:48-55.
2. Camici PG, Chiriatti G, Lorenzoni R, Bellina RC, Gistri R, Italiani G. Coronary vasodilation is impaired in both hypertrophied and non-hypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991;17:879-86.
3. Inoue T, Sasaki Y, Morooka S, et al. Coronary flow reserve in patients with dilated cardiomyopathy. Am Heart J 1993;125:93-8.
4. Nitenberg A, Valensi P, Sachs R, Dalim M, Aptecar E, Attali JR. Impairment of coronary vascular reserve and Ach-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal ventricular systolic function. Diabetes 1993;32:1017-23.
5. Nahser PJ Jr, Brown RE, Oskarsson H, Winnifold MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 1995;91:635-40.
6. Uren NG, Crake T, Leffery DC, Silva R, Gavies GJ, Maseri A. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med 1994;331:222-7.
7. Dayanikli F, Grambow D, Muzil O, Mosca L, Rubenfire M, Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 1994;90:808-17.
8. Yokoyama I, Murakami T, Ohtake T, et al. Reduced coronary flow reserve in familial hypercholesterolemia. J Nucl Med 1996;37:1937-42.
9. Yokoyama I, Ohtake T, Momomura S, Nishikawa J, Sasaki Y, Omata M. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation 1996;94:3232-8.
10. Motz W, Straner BE. Improvement of coronary flow reserve after long term therapy with enalapril. Hypertension 1996;27:1031-8.
11. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
12. Laakso M. Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. Ann Intern Med 1996;124(1 Pt. 2):127-30.
13. 13N-ammonia myocardial imaging at rest and with exercise in normal volunteers. Circulation 1989;80: 1328-37.
14. 13N-ammonia and reoriented dynamic positron emission tomography. Circulation 1992;86:1004-17.
15. Tasca C, Stefaneanu L, Vasilescu C. The myocardial microangiopathy in human and experimental diabetes mellitus: a microscopic, ultra-structual, morphometric and computer-assisted symbolic-logic analysis. Endocrinologie 1986;24:59-69.
16. 2 in experimental diabetes. Am J Physiol 1982;243:H252-8.
17. Lee JC, Downing SE. Coronary dynamics and myocardial metabolism in the diabetic newborn lamb. Am J Physiol 1979;237:H118-24.
18. Durante W, Sunahara FA, San AK. Effect of diabetes on metabolic coronary dilatation in the rat. Cardiovasc Res 1989;23:40-5.
19. Yamazaki Y, Kawamori R, Matsushima H, et al. Asymptomatic hyperglycemia is associated with increased intimal plus medial thickness of the carotid artery. Diabetologia 1995;38:585-91.
20. Kunjatjoor W, Wilson DL, LeBoeuf RC. Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest 1996;97:1767-73.
21. Samaha FF, Heinman FW, Ince C, Fleming J, Balaban RS. ATP-sensitive potassium channel is essential to maintain basal coronary tone in vivo. Am J Physiol 1992;262:C1220-7.
22. Aversano T, Ouyang P, Silverman H. Blockade of the ATP-sensitive hyperemia in the canine potassium channel modulates reactive hyperemia in the canine coronary circulation. Circ Res 1991;69:618-22.
23. Kanatsuka H, Sekiguchi N, Sato K, et al. Microvascular site for reactive hyperemia in the coronary circulation of the beating canine heart. Circ Res 1992;71:912-22.
24. Czernin J, Muller P, Chan S, et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 1993;88:62-9.
25. Mintz GS, Painter JA, Pichard AD, et al. Atherosclerosis in angiographically normal coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995;25:1479-85.
26. Sakuma I, Akaishi Y, Fukao M, et al. Dipyridamole potentiates the anti-aggregating effect of endothelium-derived relaxing factor. Thromb Res Suppl 1990;12:87-90.
27. Bult H, Fret HRL, Jordeans FH, Herman AG. Dipyridamole potentiates the anti-aggregating and vasodilator activity of nitric oxide. Eur J Pharmacol 1991;199:1-8.
28. Kinsella JP, Torielli F, Ziegler JW, Ivy DD, Abman SH. Dipyridamole augmentation of response to nitric oxide. Lancet 1995;346:647-8.
29. Chan SY, Brunken RC, Czerrnin J, et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol 1992;20:979-85.
30. Krivokapitch J, Stevenson L, Kobashigawa J, Huang S, Schelbert HR. Quantification of absolute myocardial perfusion at rest and during exercise with positron emission tomography after human cardiac transplantation. J Am Coll Cardiol 1991;18:512-7.
31. Chan SY, Kobashigawa J, Stevenson LW. Myocardial blood flow at rest and during pharmacological vasodilation in cardiac transplant during and after successful treatment of rejection. Circulation 1994;90:202-12.
32. Di Carli MF, Czernin J, Hoh CK, et al. Relation among stenosis severity, myocardial blood flow and flow reserve in patients with coronary artery disease. Circulation 1995;91:1944-51.
33. Czernin J, Auerbach M, Sun KT, Phelps M, Schelbert HR. Effects of modified pharmacologic stress approaches on hyperemic myocardial blood flow. J Nucl Med 1995;36:575-80.
34. Bottcher M, Czernin J, Sun KT, Phelps ME, Schelbert HR. Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation. J Nucl Med 1995;36:2016-21.
35. Wu HM, Hoh CK, Buxton DB, et al. Quantification of myocardial blood flow using dynamic nitrogen-13-ammonia PET studies and factor analysis of dynamic structure. J Nucl Med 1995;36:2087-93.
36. Hutchins G, Schwaiger M, Rosenspire KC, Krivokapitch J, Schelbert HR, Kuhl DE. Noninvasive quantification of regional myocardial blood flow with N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990;15:1032-42.
37. Schelbert HR, Phelps ME, Huang SC, et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation 1981;63:1259-72.
38. 3 myocardial extraction and clearance on flow and metabolism. Am J Physiol 1982;242:H536-42.